Veloxis Pharmaceuticals, Inc.

NC · United States · Reporting entity ID 100000151661

Total reported 2019–2025

$10.6M

#473 of 2,960 reporting companies — 0% of all reported industry payments

$2.41M in general payments across 7,675 records, plus $8.20M in research funding across 281 records.

How it breaks down

General payments $2,409,476

Research funding $8,199,623

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.